focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Major Distribution Agreement

9 Jan 2006 07:01

Provexis PLC09 January 2006 9 January 2006 PROVEXIS PLC ("Provexis" or the "Company") Further Major Distribution Agreement for SircoTM Provexis, the nutraceutical company that develops scientifically-provenfunctional and medical foods, announces a further distribution agreement with amarket leading supermarket chain for its SircoTM heart health juice drink. From February 2006, SircoTM Blueberry & Apple variety will be stocked inapproximately 200 of this supermarket's key premier stores bringing the total UKdistribution base for SircoTM to over 500 stores by the end of February 2006. Further to the Company's announcement released on 16 December 2005, SircoTM isnow available in 211 Sainsbury's stores and is expected to be available in 100stores of the second multiple supermarket chain from 23 January 2006. SircoTM is the first heart health product to contain the patented FruitflowTMtechnology. FruitflowTM was developed by Provexis in order to help regular"healthy" consumers reduce the risk of heart attack and stroke. The naturalbioactive works by reducing blood platelet aggregation ("thinning the blood"), a significant contributing factor to a thrombosis (internal blood clot). SircoTMcarries the health claim "Helps to Maintain a Healthy Heart and BenefitsCirculation" and is approved by the leading heart health charity, HEART UK. Commenting on the expanded distribution, Dr Stephen Franklin, CEO of Provexis,said: "We are delighted to have secured a listing with a third major retailer. Thedistribution base of SircoTM is expanding on schedule and will be sufficientlyestablished to maximise the nationwide, multimedia, advertising campaign whichwill run throughout the Spring and early Summer". For further information please contact: Provexis plcDr Stephen Franklin 020 8392 6631 Bell Pottinger Corporate & FinancialAnn-Marie Wilkinson/Emma Kent 020 7861 3232 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.